Apoptosis occurs through a sequence of specific biochemical and morphological alterations that define the progress of cell death. The changes of the mitochondrial inner membrane potential (DC m ), the release of cytochrome c to the cytosol, the apoptotic volume decrease (AVD) and the activation of caspases have been measured in RAW 264.7, HeLa and Jurkat T cells incubated with molecules that induce apoptosis through the mitochondrial pathway. Our data show that NO, staurosporine, etoposide and camptothecin increased DC m in macrophages but not in HeLa and Jurkat cells, that exhibited a DC m decrease. Moreover, the apoptosis induced by NO in macrophages, but not that promoted by staurosporine, might occur in the absence of AVD. Analysis of the sequence of apoptotic manifestations shows that DC m precedes AVD and caspase activation in RAW 264.7 cells. Inhibition of AVD abrogates apoptosis in HeLa and Jurkat T cells regardless of the stimuli used. These data suggest that the changes of DC m are cell-type dependent and that AVD is dispensable for apoptosis in macrophages.
Introduction
Apoptosis occurs through a series of well defined sequential biochemical changes that conform the apoptotic phenotype. 1 ± 3 Cell volume loss has been recognized as an early event occurring almost in all apoptotic cells. 4 ± 7 However, the relevance of this normotonic cell shrinkage in relation to the occurrence of apoptotic death has been a subject of debate. Various groups, working with different cells, reported that cell shrinkage occurs early the apoptotic process, preceding other biochemical and morphologic changes such as release of cytochrome c from the mitochondria, activation of caspases and DNA cleavage, 7 ± 9 but following rapid signaling events such as the loss of DC m and the activation of several early protein kinase cascades. 10 ± 12 Inhibition of apoptotic volume decrease (AVD) impaired apoptosis in various cell types, whereas pharmacological inhibition of caspases in HeLa and U937 cells did not affect AVD. 7, 8 However, broad spectrum inhibitors of caspases (for example, z-VAD.fmk) abrogated AVD and cell death in thymocytes and B lymphocytes. 13, 14 AVD appears to be due to K + release from cells via K + channels in an electroneutral way implying an efflux of anions and water, the latter responsible for cell shrinkage. 7, 8 In agreement with these suggestions, cell shrinkage caused by hyperosmotic stress or K + ionophores induced apoptosis. 7, 15, 16 Conversely, inhibitors of K + channels prevented, at least partially, AVD and apoptosis in various cell types. 14, 17 Most of these studies have been accomplished inducing apoptosis with molecules that interfere in mitochondrial function such as staurosporine, etoposide and camptothecin. 7 Under these conditions, an early apoptotic event is the irreversible loss of DC m . 18, 19 However, NO-induced apoptosis in macrophages, a mechanism that contributes to the resolution of inflammation, involves a sustained increase in DC m compatible with the release of mitochondrial mediators of apoptosis. 20, 21 In view of the precedent data we decided to investigate whether a relationship exists between the changes of DC m , AVD and apoptosis in three distinct cell types: the macrophage cell line RAW 264.7, Jurkat T cells and HeLa cells and using NO, staurosporine, etoposide and camptothecin as inducers of apoptosis. Our data show that these molecules promote a rapid increase in DC m in macrophages, followed by AVD, release of cytochrome c, activation of caspases and DNA fragmentation. Inhibition of AVD abrogates apoptosis except in RAW 264.7 cells treated with NO donors. However, in HeLa and Jurkat cells, NO and staurosporine decrease DC m at the time that apoptosis is significantly impaired by AVD inhibitors. These results indicate that the changes of DC m leading to apoptosis are cell typedependent and the requirement of AVD for apoptosis progression is dispensable under certain circumstances.
Results
Cell type-speci®c changes of DC m during apoptosis
The effect of molecules that promote the release of mitochondrial mediators of apoptosis on the changes of DC m was analyzed in different cell types. As Figure 1A ,B shows, treatment of RAW 264.7 cells with staurosporine, etoposide, camptothecin and NO-donors, or activation with LPS plus IFNg to express NOS-2, promoted apoptosis through a mechanism that involved an increase in CMXRos fluorescence that can be associated with a rise in DC m . Inhibition of NO synthesis by 1400 W 21 in cells stimulated with LPS and IFNg impaired DC m changes and other apoptotic manifestations, indicating that apoptosis is mainly dependent on the synthesis of NO under these conditions of macrophage activation. On analysis, NO and other proapoptotic stimuli, produced an increase in the fluorescence of CMXRos that was reverted upon mClCCP treatment ( Figure 1D ). Moreover, when the release of cytochrome c from the mitochondria to the cytosol was measured, all inducers of apoptosis promoted its release, and agreement was observed between the increase in CMXRos fluorescence, the cytosolic levels of cytochrome c and the in vitro activation of caspases 9 and 3 ( Figure 1C ± F) . In addition to macrophages, the same panel of pro-apoptotic stimuli was assayed in Jurkat and HeLa cells. As Figure 2A ,B shows, GSNO, staurosporine, etoposide and camptothecin induced apoptosis in Jurkat T cells, and a decrease in DC m was observed in all these conditions. When the DEVDase activity was measured, the values exhibited a profile that paralleled the decrease of CMXRos fluorescence. As expected, DEVDase activity and apoptosis (not shown) were inhibited by z-VAD ( Figure 2C ). Similar results were obtained in HeLa cells although camptothecin promoted an important DEVDase activation and DNA fragmentation, with a minor decrease in CMXRos fluorescence (Figure 3) . These results suggest that, depending on the cell type, an increase (macrophages) or decrease (Jurkat and HeLa) in DC m occurs during apoptosis, and that the irreversible 
NO-dependent apoptosis in macrophages may occur in the absence of apoptotic volume decrease (AVD)
The relevance of AVD on the apoptosis induced by NOdonors and staurosporine was investigated in RAW 264.7 and HeLa cells. As Figure 4A ,B shows, incubation of RAW 264.7 cells with phloretin and SITS, two inhibitors of volumesensitive Cl 7 channels, 7 abrogated the apoptosis induced by staurosporine, but not that triggered by NO. Indeed, both phloretin and SITS suppressed AVD in these cells. Under conditions of AVD inhibition, the increase in DC m induced by GSNO and staurosporine and characteristic of RAW 264.7 cells, was significantly inhibited ( Figure 4C ). However, the release of cytochrome c to the cytosol and the activation of DEVDase were unaffected by phloretin and SITS in cells treated with GSNO, but were markedly impaired in cells incubated with staurosporine ( Figure 4D ,E). In view of the specific effects of NO in macrophage apoptosis the time course of the values of DC m , the in vivo activation of caspase 3 (using cells loaded with PhyPhyLuxG1D2) and the average cell volume were determined. As Figure 5A ± C shows, the increase in CMXRos fluorescence was very rapid and preceded AVD and caspase 3 activation. Interestingly, SITS inhibited AVD, and to a lesser extent DC m , but failed to prevent the release of cytochrome c ( Figure 4B ) and in vivo activation of caspase 3 ( Figure 5 ). A microphotograph of cells corresponding to each incubation condition at 1 h is shown in Figure 5D . When experiments similar to those performed with RAW 264.7 macrophages were repeated in HeLa cells, AVD inhibitors prevented efficiently the apoptosis induced by GSNO and staurosporine and blocked the changes of CMXRos fluorescence, cytochrome c release and DEVDase activation ( Figure 6A ± D) . These results stress the relevance of cell-specific regulation of apoptotic pathways and, at the same time, suggest the existence of a cross regulation between the different steps involved in the apoptotic response. A summary of the contribution of early events to apoptosis in the distinct cell types analyzed is shown in Table 1 .
Discussion
The relevance of the loss of DC m as an early event preceding the release of mitochondrial mediators of apoptosis has been established in various cell types. 1 ± 3 However, in HeLa cells treated with UV radiation, DC m changes followed the release of cytochrome c to the cytosol, an event that was not prevented by permeability transition inhibitors. 22 Moreover, an increase in DC m has been described in macrophages undergoing NO-dependent apoptosis. 20 Here we show that incubation of macrophages with GSNO, camptothecin, etoposide and, to a lesser extent staurosporine, increased DC m . However, NO and the other apoptogenic stimuli decreased DC m in HeLa and Jurkat T cells 20, 23 (and this study). The changes of DC m have been measured following the fluorescence of CMXRos but similar Table I . Changes of parameters involved in early apoptotic signaling in different cell types. Cells were treated as described for Figure 1 . Cell Death and Differentiation AVD-independent apoptosis in NO-treated macrophages S Hortelano et al results were obtained with other probes such as JC1 (tetrachlorotetraethylbenzimidazolylcarbocyanine iodide) and Dioc 6(3) (3,3'-dihexyloxacarbocyanine iodide; not shown). These data indicate that the cell type is an important factor determining the irreversible (increase or decrease) change of DC m during apoptotic stimulation. However, regardless of the sign of the DC m changes, a release of cytochrome c from the mitochondria to the cytosol was observed in all cases and this was sufficient for the activation of the caspase cascade. The other objective investigated in this study was the relevance of AVD on apoptosis, in particular in response to NO challenge. NO released at low doses, such as those achieved after activation of the NOS-3 isoenzyme by Ca 2+ / calmodulin, has been usually associated with the activation of K + channels in vascular smooth muscle and endothelial cells, and accounted for the vasodilation capacity of NO. 24, 25 Moreover, the existence of a K + /Cl 7 cotransport regulated by NO has been proposed. 26 However, it is possible that at higher doses NO modifies the activity of K + channels through other mechanisms, including nitrosylation reactions. 27 Indeed, a selective specificity has been described for different K + channels 28 and, for example, inhibition of the K + outward efflux depending on the ether-a- gogo-related gene-1 (hERG1) was found to be inhibited by high concentrations of NO donors. 29 In the context of apoptosis dependent on the activation of K + channels, an enhanced survival of vascular smooth muscle cells that overexpress Bcl-2 has been associated to a lower activity of the K + channel. 30 Also, inhibitors of K + channels attenuate apoptosis in various cell types.
Requirement of AVD
17,31 ± 33 These data suggest that cells can support physiological activation of the K + channels without effects on cell viability, and only when the intracellular K + concentration is below a critical level, established by several groups around 50 ± 100 mM, that cells display the characteristic AVD. 5, 14, 31 In the systematic study carried out by Maeno et al., 7 inhibition of AVD suppressed apoptosis in different cell types treated with stimuli that involved the release of mitochondrial mediators as well as the activation of apoptotic pathways through plasma membrane receptors (TNF-a plus cycloheximide). We confirmed that inhibition of AVD prevented apoptosis in most circumstances, except in macrophages treated with apoptogenic doses of NO. However, this AVDindependent apoptosis induced by NO appears to be cell specific since it was observed in macrophages, but not in HeLa and Jurkat T cells. Moreover, staurosporine-induced apoptosis in macrophages was efficiently prevented by all AVD inhibitors assayed suggesting that the effect of NO in these cells is very specific and probably related to the functional role of NO in macrophage physiology.
The time course of AVD has been also a subject of debate. Some groups detected AVD early the apoptotic signaling, 7 whereas other described AVD after caspase activation.
14 Indeed, caspase inhibitors can prevent AVD, for example in thymocytes treated with dexamethasone 13 and in B lymphocytes incubated with TGFb. 34 In this regard, it is possible that activation of some caspases would be sufficient for the initiation of AVD, 34, 35 and this might explain the effectiveness of broad caspase inhibitors preventing AVD and apoptosis. We analyzed the changes of DC m , cell volume and activation of caspase 3 to establish the temporal sequence of these events in macrophages and concluded from these experiments that the increase in DC m occurred in the absence of measurable AVD. Moreover, caspase 3 activation and AVD started 30 min after treatment with apoptotic stimuli and exhibited a parallel profile. It is worth mentioning that inhibitors of AVD Taken together, these results indicate that different pathways convey to regulate the initial steps of apoptosis leading to the release of cytochrome c and other mitochondrial effectors, such as apoptosis inducing factor (AIF). The existence of cell type specificity in the response to a particular pro-apoptotic stimulus opens the possibility of new strategies in the regulation of apoptosis under pathological circumstances.
Materials and Methods

Chemicals
Reagents were from Roche (Mannheim, Germany), Calbiochem (Darmstadt, Germany) and Sigma (St. Louis, MO, USA). Fluorescent probes were from Molecular Probes (Eugene, OR, USA). Antibodies were from (Becton & Dickinson, San Jose, CA, USA). Culture media were from Biowhittaker (Verviers, Belgium).
Cell culture conditions
The murine macrophage cell line RAW 264.7, the human Jurkat T cell line and HeLa cells were maintained in RPMI 1640 medium supplemented with 10% FCS, L-glutamine and antibiotics.
Flow cytometric analysis of apoptosis and cell size PI staining was performed following a previous protocol. 20, 36, 37 Cells were resuspended in PBS and analyzed in a FACScan cytometer (Becton & Dickinson) equipped with a 25-mW argon laser. The quantification of the percentage of apoptotic cells was assessed using a dot plot of the forward scatter against the PI fluorescence. Cell sorting and analysis of DNA integrity of viable and apoptotic populations was performed to confirm the criteria of gating. In HeLa cells, apoptosis was determined by measuring the oligonucleosomal DNA present in the cytosol using an ELISA cell death kit (Roche) in which the histone associated DNA fragments were detected in a sandwich-enzyme-immunoassay with anti-histone and anti-DNAperoxidase antibodies, following the instructions of the supplier. Cell volume was determined by flow cytometry based on the size of latex beads of known volume. The cell size was also electronically evaluated by confocal microscopy in an MRC 1024 microscope (BioRad) using Lasersharp software.
Flow cytometric analysis of DC m Cells were incubated for 15 min at 378C in the presence of the potential-sensitive probe CMXRos, 23 followed by analysis in a FACSscan flow cytometer. The fluorescence in the presence of 10 mM of the uncoupling agent mClCCP was measured to define the maximal decrease of DC m . The fluorescence of CMXRos in untreated cells was considered as 100%.
Release of cytochrome c from the mitochondria to the cytosol
The presence of cytochrome c in the cytosol was determined by Western blotting cell extracts obtained by controlled lysis of the plasma membrane as previously described. 20 The proteins were sizeseparated in 12% SDS ± PAGE, transferred to a PVDF membrane and incubated with anti-cytochrome c Ab (Santa Cruz). The bands recognized were visualized by the ECL technique.
In vitro and in vivo caspase assays
For in vitro assays, cell extracts were prepared in 10 mM HEPES, pH 7.9; 1 mM EDTA, 1 mM EGTA, 120 mM NaCl, 1 mM DTT, 0.5 mM PMSF, 2 mg/ml aprotinin, 10 mg/ml leupeptin, 2 mg/ml TLCK, 5 mM NaF, 1 mM NaVO 4 , 10 mM Na 2 MoO 4 and 0.5% Nonidet P-40. After centrifugation of the cell lysate the supernatant was stored at 7808C (cytosolic extract) and protein content was assayed using the Bio-Rad protein reagent. The DEVDase (corresponding mainly to caspases 3 and 7) and caspase 9 activities were determined in cell lysates using N-acetyl-DEVD-AFC and N-acetyl-LEHD-AFC as fluorogenic substrates and following the instructions of the supplier (Calbiochem). The linearity of the caspase assay was determined over a 30 min reaction period. In vivo activation of caspase 3 was measured after labeling the cells with PhiPhiLux-G1D2 (a derivative of GDEVDGI that yields a fluorescent peptide after caspase cleavage, OncoImmunin, Gaithersburg, MD, USA), and following the instructions of the supplier. 
Statistical analysis
The data shown are the mean+S.D. (n=3 ± 4). Statistical significance was determined with the Student's t -test for unpaired observations. A P50.05 was considered significant. In studies of Western blot analysis, linear correlation between increasing amounts of input protein and signal intensity were observed (correlation coefficients 40.8).
